Tianjin Lisheng Pharmaceutical announced that the company plans to use its own funds or raised funds to repurchase some of the company's shares through centralized bidding trade, for the purpose of implementing Stock-based Incentive. The repurchase price will not exceed 21.22 yuan/share, and the total amount for the repurchase will be no less than 76.5 million yuan and no more than 0.153 billion yuan.
力生制药：拟7650万元-1.53亿元回购股份
Tianjin Lisheng Pharmaceutical: plans to repurchase shares for 76.5 million yuan - -0.153 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated